What is the most common adverse drug event associated with anticoagulants?BleedingInfectionRashHeadache

When a person is taking both aspirin and warfarin (Coumadin), which adverse drug reaction is likely?Hair lossGastrointestinal bleedingDry, flaky skinJoint stiffness

What is a safety risk associated with anticoagulant or antiplatelet medications used to prevent blood clots?Increased risk for bleedingIncreased risk for urinary retentionIncreased risk for seizuresIncreased risk for constipation

What drug class is used to decrease blood clotting?AntipsychoticsAnticoagulantsAntihypertensivesAnticonvulsants

A nurse is caring for a 39-year-old female client on a medical-surgical floor. The interdisciplinary team has determined that the client is at a risk for the development of a pulmonary embolism and has therefore implemented prophylactic measures. The client is prescribed Warfarin therapy for its anticoagulant effects. Based on the nurse's understanding of the drug, the nurse confirms that the drug has reached a therapeutic level when which of the following coagulation results are obtained?The client's baseline coagulation studies:Activated partial thromboplastin time (aPTT): 30 secondsInternational normalized ratio (INR): 1.5Prothrombin time (PT): 10 secondsCassidy RhodyID: 112703Question 6Select one:1.PT 7 seconds, INR 2.52.PT 19 seconds, INR 2.03.PT 25 seconds, INR 2.14.aPTT 35 seconds, INR 3.0

Um paciente utiliza anticoagulante oral para prevenção de trombose venosa primária e o resultado de seu tempo de protrombina (TP) foi de 28,8 segundos.Pode-se dizer que o tratamento empregado está sendo o adequado? (TP controle: 12 segundos; ISI: 1,05.)A. O resultado da RNI foi 2,50, indicando que o tratamento com anticoagulante oral desse paciente permitiu deixar o TP dentro dos valores esperados.B. O resultado do TP prolongado pode indicar que a amostra foi coletada de forma incorreta, levando ao consumo de fatores da coagulação.C. O resultado do TP prolongado pode indicar que o paciente tenha alguma alteração nos fatores que participam da via intrínseca da coagulação.